It’s called SenSight * and it’s an anti-Parkinson’s ‘pacemaker’, a directional lead system developed by Medtronic for Deep Brain Stimulation (Dbs) therapy. “A directional stimulation that allows you to customize the therapy, and to provide individual and patient-specific data thanks to the sensing function for detecting brain signals”: these, explains the company, are the innovative features of the new device, used together with the neurostimulator. Percept * PC introduced to the market last year.
Read Also
- Sergio Fajardo: “On Gustavo Petro’s side, nobody” May 30, 2022
- Haiti registered more than 450 violent deaths since the beginning of the year, according to NGO May 25, 2022
- “Ocean Viking”: More migrants in the Giens waiting area Nov 24, 2022
- World Cup 2022: “Return to the daronne”, Seine-Saint-Denis launches its campaign against sports betting Nov 19, 2022
- Chasing Static: new trailer for PS1-style survival horror Aug 17, 2021
- Tesla enters into a new agreement dedicated to the supply of cobalt Jun 18, 2020
- Luck is in your hands May 22, 2020